Clinical Trial Update: To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Inavolisib in combination with Fulvestrant for breast cancer, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Fulvestrant (fulvestrant)
• Inavolisib (Inavolisib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING